SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HZNP, COUP, FRBA, MLVF
NEW YORK, Dec. 18, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Horizon Therapeutics plc (NASDAQ: HZNP)’s sale to Amgen Inc. for $116.50 in cash per share. If you are a Horizon shareholder, click here to learn more about your rights and options.
Coupa Software Incorporated (NASDAQ: COUP)’s sale to Thoma Bravo for $81.00 in cash per share. If you are a Coupa shareholder, click here to learn more about your rights and options.
First Bank (NASDAQ: FRBA)’s merger with Malvern Bancorp, Inc. Under the terms of the merger, Malvern shareholders will receive 0.7733 shares of First Bank common stock and $7.80 in cash per each Malvern common share outstanding. If you are a First Bank shareholder, click here to learn more about your legal rights and options.
Malvern Bancorp, Inc. (NASDAQ: MLVF)’s sale to First Bank for 0.7733 shares of First Bank common stock and $7.80 in cash per each Malvern common share. If you are a Malvern shareholder, click here to learn more about your rights and options.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email email@example.com or firstname.lastname@example.org.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.